<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To study the association of plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (<z:chebi fb="0" ids="17230">Hcy</z:chebi>) and polymorphism and <z:chebi fb="0" ids="17755">cystathionine</z:chebi> beta-synthase (CBS) with <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Eighty-seven patients with first-ever <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> and 80 control subjects were examined for plasma <z:chebi fb="0" ids="17230">Hcy</z:chebi> levels using high-performance liquid chromatography-fluorescence detection and for CBS polymorphism determined by amplification refractory mutation system </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The fasting plasma <z:chebi fb="0" ids="17230">Hcy</z:chebi> level was l5.28 micromol/L (95% CI 14.37-16.19 micromol/L) in the patient group, higher than that in the control group (11.32 micromol/L, 95% C1 10.47-12.16 micromol/L, P&lt;0.001) </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma <z:chebi fb="0" ids="17230">Hcy</z:chebi> levels varied with different genotypes </plain></SENT>
<SENT sid="4" pm="."><plain>No difference in genotype or allele frequencies was noted between patient group and control group (P&gt;0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: Common mutations in CBS G919A and CBS T833C lead to <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e>, which, instead of common mutations in CBS, is more directly associated with increased risk of <z:hpo ids='HP_0005305'>cerebral thrombosis</z:hpo> </plain></SENT>
</text></document>